Avaliação nutricional e metabólica de borregas alimentadas com níveis crescentes de aminoácidos protegidos / [Nutritional and metabolic evaluation of feeding lambs with growing levels of protein amino acids]

Objetivou-se avaliar a inclusão de níveis de lisina e metionina protegidas na dieta sobre os parâmetros nutricionais e metabólicos energéticos e hepáticos de borregas em crescimento. Utilizaram-se cinco borregas ½ sangue Dorper x Santa Inês, com aproximadamente oito meses de idade e peso médio de 50 ± 2,3kg, distribuídas em esquema quadrado latino 5x5 (cinco tratamentos, cinco animais e cinco períodos). Os tratamentos consistiram na inclusão de diferentes níveis de lisina e metionina protegidas da degradação ruminal (MicroPEARLS LM®) na ração, sendo: 0g, 8g, 16g, 24g e 32g por dia. A dieta era composta por silagem de milho e concentrado na relação 30V:70C. Realizou-se um ensaio de digestibilidade para determinar consumo e digestibilidade da matéria seca (CMS/DGMS), balanço de nitrogênio e metabólitos sanguíneos. O CMS (kg/dia) em relação ao peso metabólico apresentou equação linear positiva, sendo maior no tratamento que ofertou 32g de aminoácidos por dia, assim como o nitrogênio ingerido e o balanço de nitrogênio, sendo positivo em todos os tratamentos. Não houve diferença (P>0,05) para a digestibilidade da MS e o metabolismo energético e hepático. Lisina e metionina protegidas da degradação ruminal podem ser incluídas na ração de borregas em crescimento até 32g/dia sem causar efeitos negativos na digestibilidade da MS e no metabolismo.(AU)

The objective was to evaluate the inclusion of protected lysine and methionine levels on the diet, over the nutritional parameters and energetic and hepatic metabolites of growing lambs. Five lambs ½ blood Dorper x Santa Inês, with approximately eight months of age and average weight of 50kg, were distributed in a 5x5 latin square scheme (five treatments and five replicates). The treatments consisted of the inclusion of different levels of lysine and methionine protected from ruminal degradation (MicroPEARLS LM®) in the diet, being: 0g, 8g, 16g, 24g and 32g. The diet was composed of corn silage and concentrated 30V:70C in the ratio. A digestibility assay was performed to determine dry matter intake and digestibility (DMI/DDMI), nitrogen balance and blood metabolites. The DMI (kg/day) in relation to the metabolic weight had a positive linear equation, being higher in treatment 32g, as well as the ingested nitrogen and nitrogen balance, being positive in all treatments. There was no difference (P>0.05) for the digestibility of DM, energetic and hepatic metabolism. Lysine and methionine protected from ruminal degradation can be included in the diet of growing lambs up to 32g without causing negative effects on DM digestibility and metabolism.(AU)

Exigência de lisina digestível de frangos de corte machos de 22 a 42 dias de idade / Digestible lysine levels of male broilers from 22 to 42 days of age

O objetivo deste estudo foi determinar a exigência de lisina digestível para frangos de corte machos sob as características de desempenho, composição corporal e rendimento de carcaça dos animais, de 22 a 42 dias de idade. As dietas diferiram quanto aos níveis de lisina digestível, mantendo-se a relação dos demais aminoácidos com a lisina. Foram utilizados seis níveis de lisina digestível: 0,88%; 0,96%; 1,05%; 1,13%; 1,22%; e 1,30%. Distribuídos em 36 unidades experimentais de 36 aves cada, 1296 animais da linhagem Cobb - 500® tiveram as seguintes características de desempenho avaliadas: consumo de ração (CR), peso corporal (PC), ganho de peso (GP), conversão alimentar (CA), viabilidade criatória (VC) e índice de eficiência produtiva (IEP). Aos 42 dias de idade, foram selecionadas ao acaso cinco aves para avaliação do rendimento de carcaça, e duas para avaliação da composição corporal. A CA, o IEP e o rendimento de peito foram influenciados, sendo sua exigência de 1,30%, sugerindo que níveis maiores de lisina digestível que as recomendações utilizadas como base neste estudo (1,13%) trouxeram benefícios aos animais sobre essas características.(AU)

The objective of the present study was to evaluate the optimal levels of digestible lysine in the diet of male broilers, evaluating performance characteristics, body composition, and carcass yield of the animals in the final phase (22 to 42 days old). The diets differed in digestible lysine content, maintaining the relation among the other amino acids and lysine in accordance with the ideal protein concept. The six levels of digestible lysine in the diet were: 0.88%; 0.96%; 1.05%; 1.13%; 1.22%, and 1.30%. A total of 1296 animals were employed, distributed in 36 experimental units of 36 birds each. The determined performance characteristics corresponded to feed intake (FI), body weight (BW), weight gain (WG), feed conversion (FC), viability (VB), and productive efficiency index (PEI). At 42 days of age seven birds per experimental unit were selected at random, five for the estimation of yield and total carcass and commercial cut weight, and two for the evaluation of body composition. FC, animal breast yield and PEI weres influenced with requirements of 1.30%. With respect to nationally known recommendations regarding digestible lysine (1.13%), higher levels of the amino acid in the diet have brought benefits regarding the characteristics above.(AU)

Transitional metaplasia in intestinal epithelium of rats submitted to intestinal cystoplasty and treatment with L -lysine

Abstract Purpose: To evaluated the effects of L-lysine on the intestinal and urothelial epithelia in cystoplasty in rats. Methods: Twenty-eight 9-week-old rats were assigned to 4 groups: Group A (n=8) cystoplasty followed by administration of L-lysine (150 mg/kg body weight by gavage) for 30 weeks; Group B (n=8) cystoplasty + water for 30 weeks; Group C (n=6) L-lysine for 30 weeks; Group D (n=6) water for 30 weeks. Results: On histopathology with hematoxylin and eosin, mild to moderate hyperplasia transitional was observed in at the site of anastomosis in all animals submitted to cystoplasty (Groups A and B), but "transitional metaplasia" of the intestinal glandular epithelium was more accentuated in Group A (p=0.045). No inflammatory cells, dysplasia or abnormalities were observed. Staining with Alcian blue revealed a substantial reduction of goblet cells and mucins in the colon segment (Groups A and B). Conclusion: The administration of L-lysine to rats accelerated the development of transitional metaplasia in the epithelium of the colon segment in cystoplasty.

Exigência de lisina digestível para poedeiras semipesadas de 50 a 66 semanas de idade / Digestible lysine requirement for laying hens from 50 to 66 weeks of age

Com o objetivo de determinar a exigência de lisina digestível para poedeiras semipesadas no período de 50 a 66 semanas de idade, foi realizado experimento utilizando-se 150 poedeiras Shaver Brown, distribuídas em delineamento inteiramente ao acaso, com cinco tratamentos (níveis de lisina digestível: 0,79; 0,82; 0,85; 0,88 e 0,91%), seis repetições e cinco aves por unidade experimental. Foram avaliados a produção de ovos, peso médio e a massa de ovos, consumo de ração e de lisina, conversão alimentar por massa e por dúzia de ovos, gravidade específica, unidade Haugh, o índice de gema e albúmen, porcentagem de albúmen, gema e casca. O consumo de ração, a conversão alimentar por massa e dúzia de ovos, a produção, o peso e a massa de ovos não foram influenciados (P>0,05) pelos níveis de lisina digestível. Houve aumento linear no consumo de lisina (P<0,01) com o incremento dos níveis desse aminoácido nas rações. As porcentagens de albúmen, gema e casca não foram influenciadas (P>0,05) pelos níveis de lisina digestível estudados. Os níveis de lisina influenciaram de forma quadrática (P>0,05) a unidade Haugh e o índice de albúmen, sendo estimados os níveis de 0,884 e 0,868% de lisina digestível, respectivamente. Para o índice de gema, a associação do modelo quadrático ao Linear Response Plateau (LRP) estimou o nível de 0,903% de lisina digestível. Quando o objetivo é maximizar a qualidade interna dos ovos, recomenda-se o nível dietético de 0,884%, 0,868% e 0,903% de lisina digestível para unidade Haugh, índice de albúmen e índice de gema, respectivamente.

With the objective of determining the requirement of digestible lysine for brown-egg laying hens in the period from 50 to 66 weeks of age, an experiment was carried out using 150 Shaver Brown laying hens, distributed in a completely randomized design, with five treatments (digestible lysine levels: 0.79, 0.82, 0.85, 0.88 and 0.91%), six replications and five birds per experimental unit. The production of eggs, weight and the egg mass, feed intake and lysine, feed mass and dozen eggs, specific gravity, Haugh unit, yolk and albumen index, percentage of albumen, yolk and bark were analyzed. Feed intake, feed conversion per dozen of eggs s and per egg mass, egg production, egg weight and egg mass were not influenced (P>0.05) by digestible lysine levels. There was a linear increase in lysine intake (P<0.01) with increasing levels of this amino acid in the diets. The albumen, yolk and shell percentages were not influenced (P>0.05) by studied digestible lysine levels. Lysine levels had a quadratic effect (P>0.05) Haugh unit and albumen index being estimated as 0.884 and 0.868% digestible lysine levels, respectively. For yolk index, the association of the quadratic model to Linear Response Plateau (LRP) estimated the level of 0.903% digestible lysine. When the aim is to maximize the internal egg quality, a dietary level of 0.884%, 0.868% and 0.903% digestible lysine for Haugh unit, albumen index and yolk index, respectively is recommended.

Desempenho e rendimento de carcaça em frangos de corte de um a 46 dias alimentados com dietas contendo diferentes níveis de valina e reduzido teor proteico / Performance and carcass yield of broilers from 1 to 46 days fed diets containing different levels of valine and reduced protein content

Este estudo teve como objetivo avaliar as relações de valina:lisina digestíveis em dietas com teor reduzido de proteína bruta (PB) e os efeitos dessa redução sobre desempenho e rendimento de carcaça em frangos de corte. Foram utilizados 1200 pintos machos seguindo modelo inteiramente ao acaso, com seis tratamentos de seis repetições (exceto controle, com 10 repetições), compostos por 30 aves cada. O tratamento controle (T1) foi formulado conforme os níveis de proteína bruta e aminoácidos (AAs) recomendados por Rostagno et al . (2011), e os demais tratamentos (T2 a T6) tiveram seus níveis de PB reduzidos (4% em relação ao controle) e variaram em função da relação valina:lisina digestíveis, com cinco níveis equidistantes em intervalos de 0,07:1, variando de 0,63:1 e 0,91:1 (dietas até 21 dias) e de 0,64:1 e 0,92:1 (dietas após 21 dias). As seguintes características de desempenho foram avaliadas: ganho de peso, consumo de ração, conversão alimentar, viabilidade criatória e índice de eficiência produtiva. Aos 46 dias de idade, seis animais por repetição foram abatidos para determinação de rendimento de carcaça e de cortes comerciais. As diferentes relações valina:lisina digestíveis não influenciaram o desempenho dos animais (P>0,05) para nenhuma característica avaliada. A redução proteica piorou a conversão alimentar dos animais (P≤0,05) até os 21 dias. Os resultados sugerem que os níveis de valina utilizados não afetam o desempenho dos animais, apenas o rendimento de peito e que, portanto, a redução proteica não é recomendada durante as três primeiras semanas de criação.

This study aimed to evaluate valine:lysine ratios in diets with reduced content of crude protein and the effects of this reduction on the performance of broiler chickens. 1200 male chicks were used following a complete randomized design with six replicates of six treatments (except control, with 10 replicates), each one with 30 chicks. The control treatment (T1) was formulated following levels of crude protein (CP) and the amino acids (AAs) recommended by Rostagno et al. (2011), and the other treatments (T2 to T6) had reduced levels of CP (4 % compared to control) and varied in proportion valine:lysine, with 5 levels at equidistant intervals 0.07:1 ranging from 0.63:1 to 0.91:1 (up to 21 days) and from 0.64:1 to 0.92:1 (after 21 days). The performance characteristics measured were: weight gain, feed intake, feed conversion, viability and productive efficiency index. At 46 days six animals per replicate were slaughtered for evaluation of carcass and commercial cuts. The different valine:lysine ratios did not affect animal performance (P>0.05). Reducing protein impaired feed conversion (P≤.05) up to 21 days. The results suggest that levels of valine used did not affect the broilers' performance, however, breast meat yield and reduced protein are not recommended during the first three weeks.

Suplementação de lisina e metionina em associação ou não com o óleo de soja na dieta de vacas leiteiras / Supplementation of lysine and methionine in association or not with soybean oil in dairy cow diets

O objetivo do estudo foi avaliar a suplementação de lisina e metionina em associação ou não ao óleo de soja na dieta de vacas leiteiras e seus efeitos sobre a produção e a composição do leite. Doze vacas Holandesas foram distribuídas em quadrado latino 4x4, com as dietas O+LM (dieta acrescida de óleo de soja, lisina e metionina misturados na dieta total), OLM (dieta com o complexo óleo de soja/lisina e metionina fornecido separadamente da dieta total), OS (dieta acrescida de óleo de soja fornecido separadamente da dieta total) e LM (dieta acrescida de lisina e metionina fornecidos separadamente da dieta total). A produção de leite, a de proteína e a de gordura não foram afetadas pela adição de lisina e metionina associadas ou não com óleo de soja. O percentual de gordura do leite, a produção de leite corrigida para 3,5% de gordura e a produção de leite corrigida para sólidos totais reduziram-se com a adição de óleo de soja na dieta. O percentual de proteína aumentou 0,14% (p<0,05) com a adição de óleo na presença de lisina e metionina na dieta. Os resultados sugerem efeito protetor do complexo óleo/lisina e metionina da degradação ruminal na condição experimental proposta...

The aim of this study was to evaluate the effects of lysine and methionine supplementation with or without soybean oil in the diet of dairy cows on milk production and composition. Twelve Holstein cows were randomly distributed in a 4x4 latin square where the diets were O+LM (diet with soybean oil, lysine and methionine added in the total mixed ration), OLM (diet with complex soybean oil/ lysine and methionine provided as top dressed), OS (diet with soybean oil provided as top dressed) and LM (diet with lysine and methionine provided as top dressed). The milk production, milk protein and milk fat production were not affected by the addition of lysine and methionine in association or not with soybean oil in the diet. The milk fat percentage, 3.5% fat-corrected milk and solids corrected milk were reduced with increasing soybean oil in the diet. The milk protein percentage increased in 0.14% (P < 0.05) when soybean oil was added to the diet in the presence of the lysine and methionine. The results suggest a protection effect of oil/lysine and methionine complex from the rumen degradation in this experimental condition...

Efectividad de la profilaxis analgésica con clonixinato de lisina en exodoncias: ensayo clínico aleatorio / Effectiveness of preemptive lysine clonixinate in tooth extraction: a randomized controlled trial

Objetivo: Evaluar la efectividad de la profilaxis analgésica con dosis únicas de clonixinato de lisina (CL 125mg) en pacientes sometidos a extracciones dentales. Metodología: Ensayo clínico aleatorio, doble enmascaramiento placebo-controlado. Participaron pacientes ASA I y II con indicación de exodoncia dental de servicios públicos en la ciudad de Valdivia-Chile en el mes de octubre del 2012. Se asignó de manera aleatoria dos grupos: un grupo tratamiento quienes recibieron una dosis de 25mg de CL 15 minutos antes de la cirugía; y un grupo control quien recibió un placebo. A ambos grupos se indicó CL como analgésico de rescate. Mediante un cuestionario, los pacientes registraron el grado de dolor a través de una Escala Visual Análoga (EVA) durante primer día en las 7 primeras horas, después de 24 y a las 48 horas posterior a la cirugía. Además, se registró número de cápsulas de CL consumidos como rescate durante 3 días posteriores a la intervención. Se comparó el efecto analgésico observado (EVA) y el número de consumo de analgésicos adicionales entre ambos grupos mediante t-test (p<0,05). Resultados: Cincuenta y cuatro pacientes fueron intervenidos. No se encontró diferencia estadísticamente significativa entre las puntuaciones de dolor entre ambos grupos. Los pacientes con profilaxis de CL informaron similar consumo de números de cápsulas de rescate que el grupo control. Conclusión: La profilaxis analgésica con CL no demostró ser más efectiva en la reducción del dolor luego de extracciones dentales en comparación al uso de placebo y dosis postquirúrgicas.

Aim: To evaluate the effectiveness of prophylaxis with single-dose analgesic clonixinate lysine (CL 125 mg) in patients undergoing tooth extraction. Methods: A double-blind randomized placebo-controlled trial. Were included in the study patients ASA I and II with dental extraction indication in the city of Valdivia, Chile in October 2012. Were randomly assigned in two groups: the treatment group received a doses of 125mg of CL fifteen minutes before the surgery, and a control group who received placebo. Both groups used a CL as a rescue analgesic. Using a survey, patients reported the degree of pain via a visual analog scale (VAS) during the first day, at 24 and 48 hours after surgery. In addition, registered the number of CL capsules consumed as a ransom for 3 days after the surgery. We compared the analgesic effect observed in (VAS) and the number of additional analgesic consumption between the two groups using t-test (p <0,05). Results: Fifty-four patients were operated and there was no statistically significant difference between the pain scores between the two groups. Premedication patients reported the use of equal number of rescue capsules comparing with the control group. Conclusion: CL analgesic prophylaxis proved no more effective in reducing pain after tooth extraction when comparing to the use of placebo in a postoperative doses.

Inclusão de lisina digestível em dietas para leitoas dos 60 aos 100 dias de idade / Digestible lysine inclusion in diets for gilts from 60 to 100 days of age

Foi realizado um experimento utilizando-se 300 leitoas, com peso inicial de 25,00±0,54kg, para avaliar os efeitos da porcentagem de lisina digestível sobre o desempenho e a composição da carcaça de leitoas dos 60 aos 100 dias de idade. Os animais foram distribuídos em delineamento experimental de blocos ao acaso, com cinco tratamentos 0,65; 0,75; 0,85; 0,95 e 1,05% de lisina digestível, cinco repetições e 12 animais por unidade experimental. Não se observou efeito significativo dos tratamentos sobre o consumo de ração diário e o rendimento de carcaça das leitoas. A porcentagem de lisina da dieta influenciou o consumo de lisina digestível e o ganho de peso diário, que aumentaram de forma linear. O aumento na concentração de lisina digestível da dieta melhorou de forma linear a conversão alimentar e aumentou a quantidade de carne magra da carcaça. A porcentagem de lisina influenciou a espessura de toucinho das leitoas, que reduziu de forma quadrática até a porcentagem estimada de 0,87% de lisina digestível. A inclusão de 1,05% de lisina digestível na dieta, correspondente ao consumo de lisina digestível de 18,50g/dia, proporciona os melhores resultados de desempenho e quantidade de carne na carcaça de leitoas dos 60 aos 100 dias de idade.

The experiment was conducted with 300 gilts with initial weight of 25.00±0.54kg, from 60 to 100 days of age, to evaluate the effects of digestible lysine percentages on performance and carcass traits of the animals. The gilts were allotted in a randomized block design, with five treatments (percentages of digestible lysine), five replicates, and twelve animals per experimental unit. The treatments applied were 0.65; 0.75; 0.85; 0.95 and 1.05% of digestible lysine. No effects of treatments on the daily feed intake of the gilts were observed. A linear increase on digestible lysine intake as a result of increasing the concentration of digestible lysine in the diet was verified. The increase in dietary digestible lysine concentration resulted in a linear increase of daily weight gain. The increase of digestible lysine concentrations in the diet resulted in a linear improvement of feed conversion and in a linear increase in the amount of lean meat in the carcass. There was no effect of digestible lysine concentration on gilts' carcass traits. The amount of lean meat in the carcass of pigs increased linearly with the increase of the percentage of digestible lysine in the diets. The percentage of digestible lysine influenced the back fat thickness of the gilts which decreased quadratically up to 0.87% digestible lysine maximum response. The inclusion of 1.05% digestible lysine in the diet, corresponding to a daily intake of 18.5 g digestible lysine provides the greatest performance results and amount of lean meat in the carcass of gilts from 60 to 100 days of age.

Composición proximal y contenido de lípidos y colesterol de la carne de cerdos alimentados con harina de pijiguao (Bactris gasipaes Kunth) y lisina sintética

Se condujeron dos experimentos para evaluar la composición proximal y el contenido de lípidos y colesterol de la carne de cerdos alimentados con dietas en las que se añadió harina de pijiguao (HP) con y sin adición de lisina sintética (LIS). En el experimento I, se utilizaron 24 cerdos en crecimiento distribuidos al azar en seis tratamientos con tres niveles de HP (0, 16 y 32%) y dos niveles de LIS (0 y 0,27%). En el experimento II se utilizaron 16 cerdos en engorde alimentados con dos niveles de HP (0 y 17,50%) y dos niveles de LIS (0, y 0,27%). Al final de cada experimento (42 y 35 días, respectivamente), los cerdos fueron sacrificados y se obtuvieron muestras de lomo para determinar el contenido de proteína cruda, materia seca, humedad, cenizas, lípidos totales y colesterol. En el experimento I, las carnes provenientes de animales con 16% HP, presentaron más materia seca (26,45 g/100 g) y menos humedad (73,49 g/100 g) que las carnes de 32% HP (25,11 y 75,03 g/100g), respectivamente). Las carnes de los cerdos sin LIS presentaron mayor (p.

Two experiments were conducted to evaluate the proximal composition , lipids and cholesterol content of meat from pigs fed diets with peach-palm meal (PPM), with or without addition of synthetic lysine (LYS). In experiment I, 24 pigs were randomly allotted into six treatments with three levels of PPM (0, 16 and 32%) and two levels of LYS (0 and 0.27%). In experiment II, 16 finishing pigs were fed with two levels of PPM (0 and 17.50%) and two levels of LYS (0 and 0.27%). At the end of each experiment (42 and 35 d, respectively), pigs were slaughtered and loin samples were obtained to determine crude protein, dry matter, moisture, ash, total lipids, and cholesterol content. In experiment I, pork loin from 16% PPM had more dry matter (26.45 g/100 g) and less moisture (73.49 g/100g) than pork loin from 32% PPM (25.11 y 75.03 g/100g, respectively). Meat samples from pigs without LYS had higher (p.

Relação entre os níveis de lisina da dieta e as características de desempenho de codornas de corte EV2, durante o período de crescimento / Relationship between lysine level in the diets and performance of EV2 meat-type quails during the growing period

Estudou-se a exigência de lisina total para a linha EV2 de codornas de corte na fase de crescimento. Foram utilizadas 312 codornas de corte EV2, de ambos os sexos, em delineamento experimental inteiramente ao acaso, cujos tratamentos consistiram de dietas com seis níveis lisina total - 1,4; 1,5; 1,6; 1,7; 1,8 e 1,9 por cento - e quatro repetições de 13 codornas por unidade experimental. Para avaliação do desempenho, estudaram-se peso corporal ao final de cada período (g), ganho de peso (g), consumo alimentar (g) e conversão alimentar (g de alimento/g de peso) durante os períodos experimentais inicial (nascimento ao 21º) e total (nascimento ao 42º dia de idade). No período inicial, houve efeito significativo dos níveis de lisina total da dieta sobre o peso corporal, ganho de peso, consumo e conversão alimentar, com máximo desempenho das codornas nos níveis de 1,66; 1,66; 1,40 e 1,59 por cento de lisina total, respectivamente. Para o período total de criação, houve também efeito quadrático dos níveis de lisina da dieta sobre o peso corporal ao 42º dia, ganho de peso, consumo e conversão alimentar, com os pontos de máximo desempenho estimados em 1,62; 1,62; 1,60 e 1,61 por cento, respectivamente. A exigência de lisina total para o máximo ganho de peso de machos e fêmeas de codornas de corte do nascimento ao 21º dia é estimada em 1,66 por cento e do nascimento ao 42º dia de idade, em 1,62 por cento da dieta.

The total lysine requirements for EV2 meat-type quails during the growing phase were evaluated in a completely randomized experimental design, using 312 quails of both genders, with six levels of total lysine (1.4; 1.5; 1.6; 1.7; 1.8; and 1.9 percent), four replicates of thirteen quails per experimental unit. Body weight (g), weight gain (g), feed intake (g), and feed:weight gain ratio were recorded for all the experiment and growing period (initial - from birth to 21 days and total - from birth to 42 days of age). Significant effects of total lysine level on body weight, weight gain, feed intake, and feed:weight gain ratio were observed from birth to 21 days of age, with maximum performance for quails fed 1.66; 1.66; 1.40; and 1.59 percent of total lysine in the diets, respectively. Quadratic effects of total lysine level on body weight at 42 days of age and weight gain, feed intake, and feed:weight gain ratio, were observed with estimated maximum performance for quails fed 1,62; 1.62; 1.60; and 1.61 percent of total lysine in the diets, respectively. The total lysine requirement for maximum weight gains for males and females from birth to 21 days of age was estimated in 1.66 percent and from birth to 42 days of age in 1.62 percent of the diet.

Desempenho de codornas de corte EV1 alimentadas com diferentes níveis de lisina na dieta / Performance of EV1 meat type quail line fed different lysine level diets

Estudou-se a exigência de lisina total para a linha EV1 de codornas de corte na fase de crescimento utilizando-se 288 aves, de ambos os sexos, em delineamento experimental inteiramente ao acaso, cujos tratamentos consistiram de dietas com seis níveis de lisina total, 1,4; 1,5; 1,6; 1,7; 1,8 e 1,9 por cento, e quatro repetições de 12 codornas por unidade experimental. Estudaram-se o ganho de peso (g), o peso corporal ao final de cada período (g), o consumo alimentar (g) e a conversão alimentar (g de alimento/g de peso) nos períodos inicial (do nascimento ao 21º dia) e total (do nascimento ao 42º dia de idade). No período inicial não se observou efeito do nível de lisina sobre o consumo alimentar, mas houve efeito quadrático sobre o peso corporal, ganho de peso e conversão alimentar, com máximo desempenho nos níveis de 1,74; 1,75 e 1,70 por cento de lisina total, respectivamente. Para o período total houve efeito quadrático do nível de lisina da dieta sobre o peso no 42º dia, ganho de peso, consumo e conversão alimentar, com máximo desempenho das codornas nos níveis de 1,65; 1,65; 1,62 e 1,64 por cento de lisina total, respectivamente. A exigência de lisina total para ganho de peso de machos e fêmeas de codornas de corte do nascimento ao 21º dia foi estimada em 1,75 por cento e do nascimento ao 42º dia, em 1,65 por cento da dieta

Total lysine requirements for EV1 meat type quail line, during the growing phase were evaluated in a completely randomized experimental design with four level of lysine (1.4, 1.5, 1.6, 1.8, 1.9 percent) and four replicates of 12 quails per experimental unit. The recorded traits were weight gain (g), body weight (g), feed intake (g), feed:weight gain ratio (g/g) for the initial (from hatch to 21days of age) and total period (from hatch to 42 days of age). The effects of lysine level on body weight, weight gain and feed:weight gain ratio were quadratic and significant with maximum values estimated for 1.74, 1.75 and 1.70 percent of total lysine respectively, but no effect on feed intake from hatch to 21 days of age was observed. Significant effects of lysine level on feed intake and feed : weight gain ratio from hatch to 42 days of age and on body at 42 days of age were observed, with maximum values estimated for 1.65, 1.65, 1.62, 1.64 percent of total lysine in the diets . The total lysine requirements for weight gain (males and females) from hatch to 21 days of age were estimated in 1.75 percent and from hatch to 42 days of age in 1.65 percent of the diet

Fluorescent serum and urinary advanced glycoxidation end-products in non- diabetic subjects

Introduction: Advanced glycoxidation end-products (AGEs) are involved in age-related conditions and diabetic complications. Diet intake contributes to their circulating concentrations. Aim: To measure serum and urinary AGEs in non-diabetic volunteers and relate their concentration to body composition, blood chemistry and dietary ingesti¢n. Methods: We studied 41 adult men (31 middle-aged adults and 10 elderly). A nutritional assessment including a dietary recall designed for detection of AGE ingesti¢n (specifically carboxymethyl-lysine(CML)), and anthropometric measurements were performed. Also serum lipoproteins, insulin, glucose, leptin and C reactive protein (CRP). AGEs were measured in serum and urine samples using size exclusion chromatography and flow injection assay (FIA); the technical procedures were first employed in 11 heterogeneous diabetics, as positive controls for this methodology. Results: Serum and urinary chromatograms indicated that areas under the curve were not different in younger compared with elderly adults. AGEs did not correlate with dietary intake, body composition, nor metabolic parameters, however they correlated significantly with renal function and CRP concentration. Discussion: In these non-diabetic volunteers, with low CML intake, serum and urinary concentration of AGEs were not related to dietary intake. AGEs were related to renal function and CRP, but not to body composition, lipoproteins, insulin and glucose.

Exigências de lisina, com base no conceito de proteína ideal, para suínos machos castrados dos 96 aos 120kg, selecionados para eficiência de crescimento / Lysine requirements, based on ideal protein concept, for barrows with high genetic potential for growth efficiency, from 96 to 120kg

Determinaram-se as exigências de lisina para suínos machos castrados utilizando-se 50 animais em delineamento experimental de blocos ao acaso, com cinco tratamentos (0,5; 0,6; 0,7; 0,8 e 0,9% de lisina total), cinco repetições e dois animais por baia. Adicionaram-se aminoácidos sintéticos para manter o nível de acordo com o perfil da proteína ideal. Houve efeito quadrático dos tratamentos sobre o ganho de peso diário e conversão alimentar. O modelo linear response plateau ajustou-se melhor aos dados de conversão alimentar. Observou-se aumento linear do consumo de lisina diário, espessura de toucinho na 10ª costela e espessura de toucinho na última costela. Não houve efeito sobre o consumo de ração diário, espessura de toucinho no P1, espessura de toucinho no P2, profundidade de lombo, porcentagem de carne magra, taxa de deposição de carne magra diária, rendimento de carcaça, comprimento de carcaça pelo método brasileiro, comprimento de carcaça pelo método americano e sobre o peso e rendimento dos cortes cárneos. Suínos machos castrados de 96 a 120kg, selecionados para eficiência de crescimento, exigiram 0,61% de lisina total, correspondendo ao consumo de 22,74g/dia.

Role of L-lysine HCl in adoptive immune therapy towards development of suitable tuberculosis vaccination.

L-Lysine HCI is being proposed to be a possible biocompatible adjuvant to enhance immune response by virtue of its probable non-specific bridging action and cellular proliferation properties. This proposal has been tried to be substantiated by designing an in vitro culture protocol, varying the concentration of L-lysine HCI and its further in vivo application. Splenic lymphocyte population has been extracted from mice and co-cultured with extracted mice macrophage population in presence of either Bacille Calmette Guerrin (BCG) or Hepatitis B surface antigen (HbsAg) and added L-lysine hydrochloride in culture media. Post incubation of these cultures, "taught" cell population has been adoptively transferred in naïve mice. These mice were then challenged by respective antigen dose, Change in Immune response with this challenge was noted. Antibody titre was followed in all the experiments as a measure of immune response. In adoptive immune transfer experiment of with HbsAg (AIT-HbsAg), similar to that with BCG (AIT-BCG), after the incubation period, antibody titre was higher in added lysine containing cultures in comparison with the control ones. Post transfer followed by antigen challenge, in AIT-BCG the expected augmentation in immune response was hardly visible. But in AIT-HbsAg, with the help of lysine booster, the animals responded better as far as the antibody titre is concerned.

Insulin receptor tyrosine kinase activity in monocytes of type 2 diabetes mellitus patients receiving oral L-lysine.

The action of lysine as an antidiabetic agent was examined in human volunteers. Eight patients with type 2 DM were orally supplemented with L-lysine hydrochloride 1 g/day in two doses along with antidiabetic tablets (glyciphage or chlorformine), for a period of two months. Periodically their plasma fasting sugar and insulin receptor tyrosine kinase activity was measured in their monocytes. Eight normal healthy volunteers served as controls for comparison of receptor tyrosine kinase activity. Insulin receptor tyrosine kinase was isolated from monocytes by immunoprecipitation and the activity was determined using exogenous substrate poly glu-tyr (4:1) and radioactive ATP. Phosphorylated peptide was separated by electrophoresis and quantified using a liquid scintillation system. The enzyme activity was significantly low (22074 +/- 1728 dpm/ml immunoprecipitate) in subjects with diabetes when compared to non-diabetic control group (50,775 +/- 3597). Lysine treatment enhanced the enzyme activity by 31% in patients with diabetes and decreased their blood sugar by 27%.

Oral lysine clonixinate in the acute treatment of migraine: a double-blind placebo-controlled study

Several oral nonsteroidal anti-inflammatory drugs (NSAIDs) are effective to treat migraine attacks. Lysine clonixinate (LC) is a NSAID derived from nicotinic acid that has proven to be effective in various pain syndromes such as renal colic and muscular pain. The aim of this double-blind, placebo-controlled study was to evaluate the efficacy of oral LC compared to placebo in the acute treatment of migraine. Sixty four patients with the diagnosis of migraine, according to the IHS criteria, were studied prospectively. Patients received LC or placebo once the headache reached moderate or severe intensity for 6 consecutive attacks. With regard to the moderate attacks, LC was superior than placebo after 1, 2 and 4 hours. The consumption of other rescue medications after 4 hours was significantly higher in the placebo group. With regard to the severe attacks, there was no difference between the active drug group and the placebo group concerning headache intensity and consumption of other rescue medications. We conclude that the NSAID lysine clonixinate is effective in treating moderately severe migraine attacks. It is not superior than placebo in treating severe migraine attacks

Accion del Clonoxinato de lisina sobre la funcion plaquetaria comparacion con otras drogas antiinflamatorias no esteroideas / Effects of lysine clonixinate on platelet function. Comparison with other non-steroidal anti-inflammatory agents

El grupo de los antiinflamatorios no esteroideos (AINEs) posee como uno de sus mecanismos de acción la inhibición de la síntesis de prostaglandinas. Este efecto explica muchas de las acciones farmacológicas y de los eventos adversos observados en el uso clínico. La administración de AINEs a pacientes con trastornos de la hemostasia o en estados perioperatorios incrementan el riesgo de hemorragias por inhibición de las funciones plaquetarias. En este trabajo se estudian las modificaciones plaquetarias inducidas por el clonixinato de lisina comparadas con las del diclofenac, ibuprofeno y aspirina, mediante pruebas clásicas (recuento de plaquetas, producción de factor 3 plaquetario, agregación con diversos inductores) y procedimientos más recientes (medición de P-selectina por citometría de flujo). El clonixinato de lisina no produjo modificaciones en el número ni en la función plaquetaria cuando fue administrado a voluntarios sanos en las dosis terapéuticas usuales, cosa que sí ocurrió con las drogas control.

Valoración de la eficacia analgésica y tolerancia de la combinación de acetilsalicilato de lisina + pridinol mesilato en dolor agudo de origen músculo-esquelético / Analgesic efficacy valuation and tolerance of the prodinol mesylate + acetilsalicilate of lysine combination in acute pain of musculoskeletal system

Se estudiaron treinta pacientes entre 14 y 62 años de edad con diagnósticos diversos de patología dolorosa osteo-ligamentoso-muscular, algunos con tratamiento analgésico previo no satisfactorio. No se admitieron pacientes con antecedentes alérgicos a la aspirina. El juicio global de los investigadores al final del estudio fue de resultados MUY BUENOS, no observándose fracasos, demostrando de esta manera la gran potencia analgésica del acetilsalicilato de lisina + pridinol mesilato y su utilidad en el tratamiento del dolor moderado a severo de origen músculo-esquelético. Se considera la asociación acetilsalicilato de lisina + pridinol mesilato como una nueva alternativa excelente desde el punto de vista terapéutico en afecciones dolorosas agudas del aparato locomotor

Efecto analgésico antiespasmódico y seguridad del clonixinato de lisina y bromuro de L-Butilhioscina en el tratamiento oral de la dismenorrea / Antispasmodic-analgesic effect and safety of Lysene clonixinate and Butylhioscine broide for dysmenorrhea oral treatment

Fue realizado un estudio clínico longitudinal abierto, no comparativo, en 30 mujeres con diagnóstico de dismenorrea primaria o secundaria a dispositivo intrauterino. El objetivo del estudio fue evaluar la eficacia y seguridad del compuesto terapéutico, Clonixinato de lisina y Bromuro de butihioscina 125 y 10 mg respectivamente, en cápsulas, durante un periodo de observación de tres ciclos menstruales. El tiempo de evolución de la dismenorrea primaria fue de 4.46 años; para la secundaria fue de 1.77 años. A la dismenorrea le acompañaron síntomas asociados como: náusea 92 por ciento, vómito 92 por ciento, malestar general 82.1 por ciento, pesantez abdominales 85.7 por ciento y cefalea 46.4 por ciento. Respecto a la intensidad del dolor menstrual, al inicio fue muy severo en el 10.7 por ciento, severo en 42.9 por ciento y moderado 46.4 por ciento. Al final del estudio sólo una paciente de las 28, presentó dolor menstrual de intensidad moderada. Encontramos sólo tres menciones de efectos secundarios de intensidad leve y que no requirieron tratamiento; que correspondieron a dos menciones de gastralgía y una de somnolencia. La conclusión del estudio es que la asociación analgésica espasmolítica del Clonixinato de lisina y Bromuro de butilhioscina en el tratamiento de la dismenorrea primaria o secundaria, reduce y previene el dolor menstrual, así como las manifestaciones asociadas con pocos efectos secundarios. Esta asociación analgésica espasmolítica, es eficaz y segura

Morphometric analysis of intrinsic axon terminals of Cebus monkey area 17

A morphological study of intrinsic projections in area 17 of Cebus monkey was conducted after iontophoretic injection of biocytin. Thirty axon terminals located in supragranular layers were qualitatively and quantitatively analyzed using 3-D automatic microscopy. Three types of axon terminals could be identified: Ia, Ib and II. Group I was characterized by a sparse and/or long-distance branch pattern, while type II presented compact and localized arborization. Ia axon terminals formed "clusters" and "terminaux"boutons while Ib did not. On overage, group II axon terminals tended to present straight or obtuse branching angles and a much more ramified pattern, and occupy a smaller cortical territory with shorter intermediate segments and higher density of synaptic potential sites than group I. The common characteristics of group I included innervation of larger cortical territories, longer intermediate segments, acute branching angles and lower synaptic density compared to group II. The results are compatible with the major subdivisions of neocortical neuronal morphology that classifies them as smooth and spine neurons. Smooth neurons may be related to axon terminals of group II while spine neurons may be related to group I.